Home » Neurodiagnostics Market
Neurodiagnostics Market
Published date: Nov 2021 •Formats:
Request Sample Schedule a Call

Global Neurodiagnostics Market By Product (Diagnostic and Imaging Systems, Clinical Testing instruments, Reagents & Consumables), By Indication (Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders), By End-Use (Hospitals, Specialty Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Research Laboratories & Institutes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

  • Published date: Nov 2021
  • Report ID: 73706
  • Number of Pages: 383
  • Format:
  • keyboard_arrow_up
    • 1.Neurodiagnostics Market Introduction
      • 1.1.Definition
      • 1.2.Taxonomy
      • 1.3.Research Scope
    • 2.Executive Summary
      • 2.1.Key Findings by Major Segments
      • 2.2.Top strategies by Major Players
    • 3.Global Neurodiagnostics Market Overview
      • 3.1.Neurodiagnostics Market Dynamics
        • 3.1.1.Drivers
        • 3.1.2.Opportunities
        • 3.1.3.Restraints
        • 3.1.4.Challenges
      • 3.2.COVID-19 Impact Analysis
      • 3.3.COVID-19 Impact Analysis in Global Neurodiagnostics Market
      • 3.4.PESTLE Analysis
      • 3.5.Opportunity Map Analysis
      • 3.6.PORTER'S Five Forces Analysis
      • 3.7.Market Competition Scenario Analysis
      • 3.8.Product Life Cycle Analysis
      • 3.9.Opportunity Orbits
      • 3.10.Manufacturer Intensity Map
      • 3.11.Major Companies sales by Value & Volume
    • 4.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Product Type, 2015-2031
      • 4.1.Global Neurodiagnostics Market Analysis by Product Type: Introduction
      • 4.2.Market Size and Forecast by Region
      • 4.3.Diagnostic and Imaging Systems
        • 4.3.1.EEG (Electroencephalogram) Systems
        • 4.3.2.EMG (Electromyography) Products
        • 4.3.3.MRI Systems
        • 4.3.4.CT (Computed Tomography) Scanners
        • 4.3.5.Others
      • 4.4.Clinical Testing instruments
        • 4.4.1.PCR
        • 4.4.2.Next-Generation Sequencing
        • 4.4.3.Sanger Sequencing
        • 4.4.4.Other Clinical Diagnostic Products
      • 4.5.Reagents & Consumables
        • 4.5.1.Solvents
        • 4.5.2.Enzymes, Protein & Peptides
        • 4.5.3.Probes
        • 4.5.4.Buffers
        • 4.5.5.Other Reagents
    • 5.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Indication, 2015-2031
      • 5.1.Global Neurodiagnostics Market Analysis by Indication: Introduction
      • 5.2.Market Size and Forecast by Region
      • 5.3.Epilepsy
      • 5.4.Stroke
      • 5.5.Headache Disorders
      • 5.6.Other Indications
    • 6.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2015-2031
      • 6.1.Global Neurodiagnostics Market Analysis by End-User: Introduction
      • 6.2.Market Size and Forecast by Region
      • 6.3.Hospitals
      • 6.4.Specialty Clinics
      • 6.5.Diagnostic Laboratories
      • 6.6.Ambulatory Surgical Centers
      • 6.7.Research Laboratories & Institutes
    • 7.Global Neurodiagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2015-2031
      • 7.1.North America
        • 7.1.1.North America Neurodiagnostics Market: Regional Trend Analysis
          • 7.1.1.1.U.S.
          • 7.1.1.2.Canada
          • 7.1.1.3.Mexico
      • 7.2.1.Europe
        • 7.2.1.Europe Neurodiagnostics Market: Regional Trend Analysis
          • 7.2.1.1.U.K.
          • 7.2.1.2.Germany
          • 7.2.1.3.France
          • 7.2.1.4.Spain
          • 7.2.1.5.Italy
          • 7.2.1.6.Russia
          • 7.2.1.7.Rest of Europe
      • 7.3.Asia-Pacific
        • 7.3.1.Asia-Pacific Neurodiagnostics Market: Regional Trend Analysis
          • 7.3.1.1.China
          • 7.3.1.2.Japan
          • 7.3.1.3.South Korea
          • 7.3.1.4.India
          • 7.3.1.5.ASEAN
          • 7.3.1.6.Rest of Asia-Pacific
      • 7.4.Latin America
        • 7.4.1.Latin America Neurodiagnostics Market: Regional Trend Analysis
          • 7.4.1.1.Brazil
          • 7.4.1.2.Argentina
          • 7.4.1.3.Rest of Latin America
      • 7.5.Middle East and Africa
        • 7.5.1.Middle East and Africa Neurodiagnostics Market: Regional Trend Analysis
          • 7.5.1.1.GCC
          • 7.5.1.2.Israel
          • 7.5.1.3.South Africa
          • 7.5.1.4.Rest of MEA
    • 8.Global Neurodiagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 8.1.Market Share Analysis
      • 8.2.Company Profiles
      • 8.3.GE Healthcare
        • 8.3.1.Company Overview
        • 8.3.2.Financial Highlights
        • 8.3.3.Product Portfolio
        • 8.3.4.SWOT Analysis
        • 8.3.5.Key Strategies and Developments
      • 8.4.Siemens Healthineers AG
        • 8.4.1.Company Overview
        • 8.4.2.Financial Highlights
        • 8.4.3.Product Portfolio
        • 8.4.4.SWOT Analysis
        • 8.4.5.Key Strategies and Developments
      • 8.5.Philips Healthcare
        • 8.5.1.Company Overview
        • 8.5.2.Financial Highlights
        • 8.5.3.Product Portfolio
        • 8.5.4.SWOT Analysis
        • 8.5.5.Key Strategies and Developments
      • 8.6.Hitachi Ltd.
        • 8.6.1.Company Overview
        • 8.6.2.Financial Highlights
        • 8.6.3.Product Portfolio
        • 8.6.4.SWOT Analysis
        • 8.6.5.Key Strategies and Developments
      • 8.7.Canon Inc.
        • 8.7.1.Company Overview
        • 8.7.2.Financial Highlights
        • 8.7.3.Product Portfolio
        • 8.7.4.SWOT Analysis
        • 8.7.5.Key Strategies and Developments
      • 8.8.Lifelines Neuro Company LLC
        • 8.8.1.Company Overview
        • 8.8.2.Financial Highlights
        • 8.8.3.Product Portfolio
        • 8.8.4.SWOT Analysis
        • 8.8.5.Key Strategies and Developments
      • 8.9.Natus Medical Incorporated
        • 8.9.1.Company Overview
        • 8.9.2.Financial Highlights
        • 8.9.3.Product Portfolio
        • 8.9.4.SWOT Analysis
        • 8.9.5.Key Strategies and Developments
      • 8.10.F. Hoffmann-La Roche AG
        • 8.10.1.Company Overview
        • 8.10.2.Financial Highlights
        • 8.10.3.Product Portfolio
        • 8.10.4.SWOT Analysis
        • 8.10.5.Key Strategies and Developments
      • 8.11.FUJIFILM Holdings Corporation
        • 8.11.1.Company Overview
        • 8.11.2.Financial Highlights
        • 8.11.3.Product Portfolio
        • 8.11.4.SWOT Analysis
        • 8.11.5.Key Strategies and Developments
      • 8.12.Mitsar Co. Ltd.
        • 8.12.1.Company Overview
        • 8.12.2.Financial Highlights
        • 8.12.3.Product Portfolio
        • 8.12.4.SWOT Analysis
        • 8.12.5.Key Strategies and Developments
      • 8.13.Advanced Brain Monitoring Inc.
        • 8.13.1.Company Overview
        • 8.13.2.Financial Highlights
        • 8.13.3.Product Portfolio
        • 8.13.4.SWOT Analysis
        • 8.13.5.Key Strategies and Developments
      • 8.14.Thermo Fisher Scientific Inc.
        • 8.14.1.Company Overview
        • 8.14.2.Financial Highlights
        • 8.14.3.Product Portfolio
        • 8.14.4.SWOT Analysis
        • 8.14.5.Key Strategies and Developments
      • 8.15.Bio-Rad Laboratories Inc.
        • 8.15.1.Company Overview
        • 8.15.2.Financial Highlights
        • 8.15.3.Product Portfolio
        • 8.15.4.SWOT Analysis
        • 8.15.5.Key Strategies and Developments
      • 8.16.QIAGEN N.V.
        • 8.16.1.Company Overview
        • 8.16.2.Financial Highlights
        • 8.16.3.Product Portfolio
        • 8.16.4.SWOT Analysis
        • 8.16.5.Key Strategies and Developments
      • 8.17.Nihon Kohden Corporation
        • 8.17.1.Company Overview
        • 8.17.2.Financial Highlights
        • 8.17.3.Product Portfolio
        • 8.17.4.SWOT Analysis
        • 8.17.5.Key Strategies and Developments
      • 8.18.ANT Neuro b.v.
        • 8.18.1.Company Overview
        • 8.18.2.Financial Highlights
        • 8.18.3.Product Portfolio
        • 8.18.4.SWOT Analysis
        • 8.18.5.Key Strategies and Developments
      • 8.19.Fonar Corporation
        • 8.19.1.Company Overview
        • 8.19.2.Financial Highlights
        • 8.19.3.Product Portfolio
        • 8.19.4.SWOT Analysis
        • 8.19.5.Key Strategies and Developments
      • 8.20.Fujirebio Diagnostics Inc.
        • 8.20.1.Company Overview
        • 8.20.2.Financial Highlights
        • 8.20.3.Product Portfolio
        • 8.20.4.SWOT Analysis
        • 8.20.5.Key Strategies and Developments
      • 8.21.DRG Instruments GmbH
        • 8.21.1.Company Overview
        • 8.21.2.Financial Highlights
        • 8.21.3.Product Portfolio
        • 8.21.4.SWOT Analysis
        • 8.21.5.Key Strategies and Developments
      • 8.22.Tecan Trading AG
        • 8.22.1.Company Overview
        • 8.22.2.Financial Highlights
        • 8.22.3.Product Portfolio
        • 8.22.4.SWOT Analysis
        • 8.22.5.Key Strategies and Developments
      • 8.23.Motion Lab Systems Inc.
        • 8.23.1.Company Overview
        • 8.23.2.Financial Highlights
        • 8.23.3.Product Portfolio
        • 8.23.4.SWOT Analysis
        • 8.23.5.Key Strategies and Developments
      • 8.24.Rigaku Corporation
        • 8.24.1.Company Overview
        • 8.24.2.Financial Highlights
        • 8.24.3.Product Portfolio
        • 8.24.4.SWOT Analysis
        • 8.24.5.Key Strategies and Developments
      • 8.25.Neusoft Medical Systems Co. Ltd.
        • 8.25.1.Company Overview
        • 8.25.2.Financial Highlights
        • 8.25.3.Product Portfolio
        • 8.25.4.SWOT Analysis
        • 8.25.5.Key Strategies and Developments
      • 8.26.ELMIKO MEDICAL Sp. Z o.o.
        • 8.26.1.Company Overview
        • 8.26.2.Financial Highlights
        • 8.26.3.Product Portfolio
        • 8.26.4.SWOT Analysis
        • 8.26.5.Key Strategies and Developments
      • 8.27.Ridge Diagnostics Inc.
        • 8.27.1.Company Overview
        • 8.27.2.Financial Highlights
        • 8.27.3.Product Portfolio
        • 8.27.4.SWOT Analysis
        • 8.27.5.Key Strategies and Developments
    • 9.Assumptions and Acronyms
    • 10.Research Methodology
    • 11.Contact
    • GE Healthcare
    • Siemens Healthineers AG
    • Philips Healthcare
    • Hitachi Ltd. Company Profile
    • Canon Inc.
    • Lifelines Neuro Company LLC
    • Natus Medical Incorporated
    • F. Hoffmann-La Roche AG
    • FUJIFILM Holdings Corporation Company Profile
    • Mitsar Co. Ltd.
    • Advanced Brain Monitoring Inc.
    • Thermo Fisher Scientific Company Profile
    • Bio-Rad Laboratories Inc.
    • QIAGEN N.V.
    • Nihon Kohden Corporation
    • ANT Neuro b.v.
    • Fonar Corporation
    • Fujirebio Diagnostics Inc.
    • DRG Instruments GmbH
    • Tecan Trading AG
    • Motion Lab Systems Inc.
    • Rigaku Corporation
    • Neusoft Medical Systems Co. Ltd.
    • ELMIKO MEDICAL Sp. Z o.o.
    • Ridge Diagnostics Inc.
    • others
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Neurodiagnostics Market
  • 73706
  • Nov 2021
    • ★★★★★
      ★★★★★
    • (87)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
Legal
Explore